From a federal judge tossing a Medicare Advantage audit rule to Florida hospitals challenging a proposed transplant rule, here are 10 ...

A variety of laboratory tests are available to determine whether a patient has good sleep health, but a simple way to ...

Medicare Part D beneficiaries experienced a large increase in out-of-pocket spending for GLP-1s in 2025, according to ...

Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors ...

SHANGHAI (Reuters) -Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ...

Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.

Discover why LLY stock is rated Buy as sales surge in diabetes & obesity drugs and new treatments drive future growth.

How important is healthcare to the economy, and to your portfolios? Medicare and Medicaid consumed $1.5 trillion of the $6.8 ...

Leveraging advanced 3D-printing technology and patented Vertex Technology, this device offers a custom-fit, patient-friendly ...

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with ...